Received Mar 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | 2 | UNK | — |
the lump from the second shot was as big as an egg/lump in arm; painful; This non-serious case was reported by a consumer and described the occurrence of local swelling in a 59-year-old female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. Previously administered products included Shingrix (recived 1st dose on 30-OCT-2024). Concurrent medical conditions included diabetes. Concomitant products included tirzepatide (Mounjaro) and empagliflozin (Jardiance). On 06-FEB-2025, the patient received the 2nd dose of Shingles vaccine. On 06-FEB-2025, less than a day after receiving Shingles vaccine, the patient experienced local swelling (Verbatim: the lump from the second shot was as big as an egg/lump in arm) and pain (Verbatim: painful). The outcome of the local swelling was resolving and the outcome of the pain was not reported. It was unknown if the reporter considered the local swelling and pain to be related to Shingles vaccine. It was unknown if the company considered the local swelling and pain to be related to Shingles vaccine. Additional Information: GSK receipt date: 05-MAR-2025 The patient reported that she had recived 2nd dose of Shingrix vaccine and experienced lump in arm. The reporter mentioned that lump from the second shot was as big as an egg and very painful. It was a smaller now, but it was lasted a month. The expiry date of Shingles vaccine was unknown.
Diabetes
Mounjaro; Jardiance